AHRQ Patient Safety Network

The Collection > Pediatrics

Narrow By

clear selections

Safety Target

•Device-related Complications (22)

•Diagnostic Errors (16)

•Identification Errors (2)

•Discontinuities, Gaps, and Hand-Off Problems (17)

•Fatigue and Sleep Deprivation (3)

•Medication Safety (125)

•Medical Complications (18)

•Nonsurgical Procedural Complications (9)

•Surgical Complications (9)

•Transfusion Complications (1)

•Psychological and Social Complications (5)

Origin/Sponsor

•Asia (2)

•Australia and New Zealand (5)

Resource Types

•Journal Article (154)

•Legislation/Regulation (5)

•Meeting/Conference (3)

•Newspaper/Magazine Article (13)

•Press Release/Announcement (7)

•Special or Theme Issue (8)

•Tools/Toolkit (1)

•Web Resource (6)

•Grant (3)

Error Types

•Epidemiology of Errors and Adverse Events (59)

•Active Errors (57)

•Latent Errors (21)

•Near Miss (5)

Approach to Improving Safety

•Quality Improvement Strategies (63)

•Legal and Policy Approaches (13)

•Error Reporting and Analysis (46)

•Communication Improvement (50)

•Human Factors Engineering (48)

•Teamwork (12)

•Specialization of Care (17)

•Logistical Approaches (14)

•Culture of Safety (23)

•Technologic Approaches (49)

•Education and Training (45)

Clinical Areas
< All

Pediatrics

•Pediatric Allergy & Immunology (3)

•Pediatric Cardiology (2)

•Pediatric Emergency Medicine (8)

•Pediatric Endocrinology (1)

•Pediatric Gastroenterology (1)

•General Pediatrics (8)

•Pediatric Hematology (1)

•Pediatric Medical Oncology (1)

•Neonatology and Intensive Care (26)

•Pediatric Nephrology (1)

Target Audience

•Health Care Providers (179)

•Health Care Executives and Administrators (133)

•Non-Health Care Professionals (65)

•Patients (28)

Setting of Care

•Hospitals (135)

•Ambulatory Care (41)

•Outpatient Surgery (4)

•Patient Transport (2)

1 - 20 of 206

Show ExcerptDon't Show Excerpt

dropdown

PRESS RELEASE/ANNOUNCEMENT

Promethazine HCl (marketed as Phenergan) Information.

FDA Alert [US Food and Drug Administration Web site]. April 25, 2006.

PRESS RELEASE/ANNOUNCEMENT

Kaletra (lopinavir/ritonavir) oral solution.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2007.

COMMENTARY

Privacy Gone Awry.

Pauker SG, Pauker SP. AHRQ WebM&M [serial online]. May 2004.

COMMENTARY

Language Barrier

Flores G. AHRQ WebM&M [serial online]. April 2006.

PRESS RELEASE/ANNOUNCEMENT

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

FDA Public Health Advisory [US Food and Drug Administration Web site]. March 11, 2008.

BOOK/REPORT

Review of Patient Safety for Children and Young People.

London, UK: National Patient Safety Agency; 2009. ISBN: 978906624071.

NEWSPAPER/MAGAZINE ARTICLE

Small patients, big consequences in medical errors.

Tarkan L. New York Times. September 14, 2008;Health section:7.

MEETING/CONFERENCE PROCEEDINGS

2005 Annual Patient Safety and Health Information Technology Conference: Making the Health Care System Safer through Implementation and Innovation.

Agency for Healthcare Research and Quality. June 6-10, 2005.

GRANT ANNOUNCEMENT

Patient Safety Research During Neonatal Care.

Bethesda, MD: National Institutes of Health. PAR-11-225; PAR-11-226; PAR-11-227.

STUDY

Systematic evaluation of errors occurring during the preparation of intravenous medication.

Parshuram CS, To T, Seto W, Trope A, Koren G, Laupacis A. CMAJ. 2008;178:42-48.

PRESS RELEASE/ANNOUNCEMENT

Vitamin D supplement products: medication use error.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; June 15, 2010.

COMMENTARY

Confusion with Acetaminophen

Heubi JE. AHRQ WebM&M [serial online]. January 2006.

COMMENTARY

To LP or not LP.

Landrigan CP. AHRQ WebM&M [serial online]. October 2003.

MEETING/CONFERENCE PROCEEDINGS

Safety in the NICU: preventing medical errors.

Stokowski LA. Highlights of the National Association of Neonatal Nurses 22nd Annual Conference [Medscape.com]. March 8, 2007.

COMMENTARY

Implementation of standard concentrations for continuous infusions using a computerized provider order entry system.

Sinclair-Pingel J, Grisso AG, Hargrove FR, Wright L. Hosp Pharm. 2006;41:1102-1106.

STUDY

An intervention to decrease narcotic-related adverse drug events in children's hospitals.

Sharek PJ, McClead RE Jr, Taketomo C, et al. Pediatrics. 2008;122:e861-e866.

STUDY

Peer review comments augment diagnostic error characterization and departmental quality assurance: 1-year experience from a children's hospital.

Iyer RS, Swanson JO, Otto RK, Weinberger E. AJR Am J Roentgenol. 2013;200:132-137.

COMMENTARY

Keeping an eye on patient safety using human factors engineering (HFE): a family affair for the hospitalized child.

Wilson BL. J Spec Pediatr Nurs. 2010;15:84-87.

ORGANIZATIONAL POLICY/GUIDELINES

Preventing pediatric medication errors.

Sentinel Event Alert. April 11, 2008;(39):1-5.

COMMENTARY

Central Line Clot.

Randolph AG. AHRQ WebM&M [serial online]. May 2003.

1 2 3 4 5 6 7 8 9 10 11 Next >